Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Frostman who wrote (3170)	12/10/1997 9:35:00 AM
From: Richard Singer	Read Replies (3) \| Respond to of 23519

Frosty- Here is the quick look at 25% revenue decline from Q3 I left expenses and other income, as well as margins and taxes, etc. same as Q3 These numbers are at expected levels of taxation-NOT fully taxed(the way Charles O.projects them): ****************************************************************** Q3 Q4 (Est.) Net Revenue 39118000 29338500 Cost of Goods Sold 11270013 8452510 Gross Margin@71% 27847987 20885990 Progress Payment 2000000 27847987 22885990 Operating Expense R&D 3947000 3947000 Selling,Gen&Admin 11507000 11507000 Total Operating Expense 15454000 15454000 Income from operations 12393986 7431990 Interest Income 1106000 1106000 Pre-tax Income 13499986 8537990 Income Tax-(16.6%) 2241000 1417306 Net Income 11258987 7120684 Net per share 0.31 0.20 Shares used in Computation 35772000 35772000 Richard